Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Constipation is a common side effect of Ozempic due to slowed gut motility and changes in fluid or fiber intake, and mild cases often improve within 1–2 weeks with hydration, diet adjustments, and gentle exercise. However, no bowel movement for more than five days, severe abdominal pain, persistent vomiting, or blood in the stool could be red flags that need prompt medical attention.
There are several factors to consider when managing Ozempic-related constipation; see below for the complete checklist with self-care strategies, warning signs, and guidance on when to consult your healthcare provider.
If you've noticed Ozempic constipation after starting your medication, you're not alone. Ozempic (semaglutide) is a popular glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for type 2 diabetes and weight management. While many people experience improved blood sugar control and appetite suppression, gastrointestinal side effects can occur. Constipation is one of the more common complaints.
This checklist will help you:
GLP-1 agonists slow gastric emptying and alter gut motility. This helps regulate blood sugar and reduce appetite, but it can also lead to:
Together, these changes can lead to harder, drier stools that are difficult to pass.
Not all constipation requires a doctor's visit, but severe or prolonged issues can signal something more serious. Use this breakdown to decide if your constipation is a typical side effect or a red flag.
If you experience any of the following, contact your healthcare provider promptly:
Use this step-by-step checklist to track your symptoms and actions:
Many cases of Ozempic-related constipation improve with basic measures:
• Stay hydrated
• Eat fiber-rich foods gradually (soluble and insoluble)
• Move your body daily
• Try natural stool softeners (prunes, figs, chia seeds)
• Practice good toilet posture (feet slightly elevated)
If you start a laxative or fiber supplement, introduce it slowly to avoid gas or cramping. Always read labels and follow dosing instructions.
Sometimes your provider may:
Never alter your Ozempic dose on your own. Always discuss changes with your prescribing clinician.
Although mild constipation is expected, seek medical advice if you notice:
These signs could indicate complications like bowel obstruction or ischemia, which require prompt evaluation.
When you talk to your healthcare team:
Clear, detailed information helps your provider decide whether basic management is enough or if further testing is needed (e.g., abdominal imaging, blood work).
Constant or severe constipation might be a warning sign. Never hesitate to reach out to your healthcare provider if you're concerned. They can tailor your Ozempic regimen or recommend additional treatments to keep you safe and comfortable.
Always speak to a doctor about anything that could be life-threatening or serious.
(References)
* Sattar N, et al. Gastrointestinal Adverse Events with Tirzepatide and Semaglutide: A Systematic Review and Meta-analysis. Obesity (Silver Spring). 2023 Dec;31(12):3049-3062. doi: 10.1002/oby.23927. Epub 2023 Sep 28. PMID: 37766974.
* Heckman-Stoddard BM, et al. Navigating the Gastric Maze: Clinical Insights and Practical Approaches to Gastrointestinal Side Effects with GLP-1 Receptor Agonists. Diabetes Ther. 2024 Jan;15(1):15-32. doi: 10.1007/s13300-023-01509-9. Epub 2023 Dec 16. PMID: 38104523; PMCID: PMC10738479.
* Wu Y, et al. Gastrointestinal adverse events from GLP-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Expert Rev Gastroenterol Hepatol. 2023 Mar;17(3):295-306. doi: 10.1080/17474124.2023.2185244. Epub 2023 Mar 13. PMID: 36856578.
* Davies MJ, et al. Management of gastrointestinal side effects with GLP-1 receptor agonists. Diabetes Obes Metab. 2022 Oct;24 Suppl 2:37-45. doi: 10.1111/dom.14819. PMID: 36030999; PMCID: PMC9790678.
* Nauck MA. Strategies to Mitigate Gastrointestinal Side Effects of Glucagon-Like Peptide-1 Receptor Agonists. Diabetes Obes Metab. 2021 Mar;23 Suppl 1:33-40. doi: 10.1111/dom.14282. Epub 2021 Jan 12. PMID: 33432729; PMCID: PMC8048604.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.